Sanofi CEO Hudson Delivers An Ambitious Turnaround Agenda

CEO Paul Hudson came to Sanofi's capital markets day with big news and key messages for investors about the company's future business model. 

SC1912_U-Turn_219745594_1200.jpg
Sanofi's new CEO laid out plans for a turnaround • Source: Shutterstock

Sanofi will make tough investment decisions, double down on a more focused pipeline, cut spending and restructure its business units, including separating out consumer health care. Those were key takeaways from the company's capital markets day on 10 December in Cambridge, MA, where CEO Paul Hudson outlined his turnaround plan for the company.

The new chief executive came to the meeting, 100 days into the job, with a strong message for investors and an actionable plan for the company to execute on

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business

Roche Reveals Another US Manufacturing Site As Tariff Pressures Seem To Ease

 
• By 

Roche/Genentech unveiled plans for a $700m-plus manufacturing facility for weight loss drugs in North Carolina as President Trump signaled such investments could mean no tariffs for pharma.

Trump’s MFN Executive Order More Rhetoric Than Action

 

The details of Trump’s latest executive order on drug pricing are vague and the president put more blame on other countries and pharma distributors than drug companies.

Biopharma Deals ROI Has Fallen And Market Instability Could Make It Worse

 

Rising biotech valuations mean return on investment on some deals is non-existent for big pharma, though certain strategies will improve chances of success, a new analysis has found.